Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with Cystic Fibrosis (CF):
- A diagnosis of CF confirmed by a sweat chloride test result above 60 mEq/L, and/or the detection of two CF-causing gene changes alongside signs of organ involvement
For healthy volunteers (control group):
- People who are a similar age to those in the CF group
Who may not be able to join:
For people with Cystic Fibrosis (CF):
- Cases where the patient or their family is unable or unwilling to cooperate with the study
For healthy volunteers (control group):
- People who have other conditions known to cause stomach or digestive symptoms, such as inflammatory bowel disease, alpha-1 antitrypsin deficiency, coeliac disease, food allergy, or gastroenteritis, among others
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jochen G Mainz, Prof. MD, Medizinische Hochschule Brandenburg (MHB), University
Phone: +493381411803
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Development and evaluation of the CFAbd-Score (initially named JenAbdomen CF-Score), a CF-specific PROM following FDA recommendations; Development and evaluation of a diary for assessment and quantification of abdominal symptoms, a CF-specific PROM following FDA recommendations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.